PL1800693T3 - Terapia adiuwantowa z zastosowaniem przeciwciała przeciw glipikanowi 3 - Google Patents

Terapia adiuwantowa z zastosowaniem przeciwciała przeciw glipikanowi 3

Info

Publication number
PL1800693T3
PL1800693T3 PL05780979T PL05780979T PL1800693T3 PL 1800693 T3 PL1800693 T3 PL 1800693T3 PL 05780979 T PL05780979 T PL 05780979T PL 05780979 T PL05780979 T PL 05780979T PL 1800693 T3 PL1800693 T3 PL 1800693T3
Authority
PL
Poland
Prior art keywords
glypican
antibody
adjuvant therapy
adjuvant
therapy
Prior art date
Application number
PL05780979T
Other languages
English (en)
Inventor
Yasuko Kinoshita
Masamichi Sugimoto
Hisafumi Okabe
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of PL1800693T3 publication Critical patent/PL1800693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
PL05780979T 2004-08-24 2005-08-23 Terapia adiuwantowa z zastosowaniem przeciwciała przeciw glipikanowi 3 PL1800693T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004244273 2004-08-24
JP2005090945 2005-03-28
PCT/JP2005/015607 WO2006022407A1 (ja) 2004-08-24 2005-08-23 抗グリピカン３抗体を用いたアジュバント療法
EP05780979.0A EP1800693B1 (en) 2004-08-24 2005-08-23 Adjuvant therapy with the use of anti-glypican 3 antibody

Publications (1)

Publication Number Publication Date
PL1800693T3 true PL1800693T3 (pl) 2013-12-31

Family

ID=35967605

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05780979T PL1800693T3 (pl) 2004-08-24 2005-08-23 Terapia adiuwantowa z zastosowaniem przeciwciała przeciw glipikanowi 3

Country Status (13)

Country Link
US (1) US7871613B2 (pl)
EP (1) EP1800693B1 (pl)
JP (1) JP4733042B2 (pl)
KR (2) KR20130103580A (pl)
CN (2) CN102698267B (pl)
DK (1) DK1800693T3 (pl)
ES (1) ES2422898T3 (pl)
HK (1) HK1107010A1 (pl)
PL (1) PL1800693T3 (pl)
PT (1) PT1800693E (pl)
SI (1) SI1800693T1 (pl)
TW (1) TW200612988A (pl)
WO (1) WO2006022407A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361336B1 (en) * 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
AU2002338020A1 (en) * 2002-09-04 2004-03-29 Chugai Seiyaku Kabushiki Kaisha Antibody against blood-solubilized n-terminal peptide in gpc3
ATE486610T1 (de) * 2004-07-09 2010-11-15 Chugai Pharmaceutical Co Ltd Anti-glypican-3-antikörper
EP1800693B1 (en) 2004-08-24 2013-07-17 Chugai Seiyaku Kabushiki Kaisha Adjuvant therapy with the use of anti-glypican 3 antibody
TWI468514B (zh) 2004-10-26 2015-01-11 Chugai Pharmaceutical Co Ltd Sugar chain modified phosphatidylinositol glyphosyl 3 antibody
US20070087005A1 (en) * 2005-10-14 2007-04-19 Lazar Gregory A Anti-glypican-3 antibody
JP5868593B2 (ja) 2007-07-17 2016-02-24 メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． Ｇｌｙｐｉｃａｎ−３に対するモノクローナル抗体
AU2008305851B2 (en) 2007-09-28 2014-12-18 Chugai Seiyaku Kabushiki Kaisha Anti-glypican-3 antibody having improved kinetics in plasma
CL2009000647A1 (es) * 2008-04-04 2010-06-04 Chugai Pharmaceutical Co Ltd Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
CA2768398C (en) * 2009-07-24 2020-01-07 Rhode Island Hospital Dendritic cell vaccines for asparaginyl-.beta.-hydroxylase expressing tumors
EP2412724A1 (en) * 2010-07-29 2012-02-01 Centre National de la Recherche Scientifique (C.N.R.S) Regulation of Glypican 4 activity to modulate the fate of stem cells and uses thereof
CN103561771B (zh) 2011-03-17 2019-01-04 伯明翰大学 重新定向的免疫治疗
JP6494507B2 (ja) * 2012-06-01 2019-04-03 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ グリピカン−３に対する高親和性モノクローナル抗体およびその使用
TWI693073B (zh) 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
EP3094976B1 (en) * 2014-01-17 2020-03-25 Minomic International Ltd. Cell surface prostate cancer antigen for diagnosis
SG11201609014TA (en) * 2014-05-08 2016-12-29 Chugai Pharmaceutical Co Ltd Gpc3 -targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
WO2017002934A1 (ja) 2015-07-01 2017-01-05 中外製薬株式会社 Ｇｐｃ３標的治療剤が有効である患者に投与されるｇｐｃ３標的治療剤
JP6987068B2 (ja) 2015-11-09 2021-12-22 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia 癌マーカーおよび治療標的としてのグリピカン２
EP3897851A2 (en) 2018-12-17 2021-10-27 Revitope Limited Twin immune cell engager
WO2022268196A1 (zh) * 2021-06-25 2022-12-29 天辰生物医药(苏州)有限公司 靶向gpc3的抗原结合蛋白

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0242355A (ja) 1988-08-02 1990-02-13 Hitachi Constr Mach Co Ltd 超音波検査装置
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JPH04336051A (ja) 1991-05-10 1992-11-24 Toshiba Corp 超音波診断装置
WO1993022332A2 (en) 1992-04-24 1993-11-11 Board Of Regents, The University Of Texas System Recombinant production of immunoglobulin-like domains in prokaryotic cells
US5622701A (en) * 1994-06-14 1997-04-22 Protein Design Labs, Inc. Cross-reacting monoclonal antibodies specific for E- and P-selectin
WO1998023289A1 (en) 1996-11-27 1998-06-04 The General Hospital Corporation MODULATION OF IgG BINDING TO FcRn
US7361336B1 (en) * 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
JPH11118775A (ja) 1997-10-09 1999-04-30 Canon Inc 超音波検査装置
US6528624B1 (en) * 1998-04-02 2003-03-04 Genentech, Inc. Polypeptide variants
AU3657899A (en) 1998-04-20 1999-11-08 James E. Bailey Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
US6737056B1 (en) * 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
EP2275540B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
JP3606132B2 (ja) 1999-10-14 2005-01-05 Ｊｆｅエンジニアリング株式会社 超音波探傷方法およびその装置
SI2223922T1 (sl) * 2000-04-25 2016-04-29 Icos Corporation Inhibitorji humane fosfatidil-inositol 3-kinazne delta izoforme
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
JP2002048867A (ja) 2000-08-07 2002-02-15 Mitsubishi Heavy Ind Ltd 音響探査装置
DE60128817T2 (de) 2000-09-12 2008-02-07 Union Carbide Chemicals & Plastics Technology Corp., Danbury Polymerische mischungen enthaltend ethylenoxid-copolymere
CA2424602C (en) 2000-10-06 2012-09-18 Kyowa Hakko Kogyo Co., Ltd. Antibody composition-producing cell
JP4336051B2 (ja) 2001-01-31 2009-09-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信端末、発呼制限方法及びプログラム
US20030003097A1 (en) 2001-04-02 2003-01-02 Idec Pharmaceutical Corporation Recombinant antibodies coexpressed with GnTIII
ATE407204T1 (de) * 2001-06-22 2008-09-15 Chugai Pharmaceutical Co Ltd Zellproliferationsinhibitoren mit anti-glypican-3-antikörper
US7421900B2 (en) * 2001-11-14 2008-09-09 Kabushiki Kaisha Toshiba Ultrasonograph, ultrasonic transducer, examining instrument, and ultrasonographing device
JP4087098B2 (ja) 2001-11-14 2008-05-14 株式会社東芝 超音波検査装置
JP3961359B2 (ja) 2002-07-18 2007-08-22 株式会社東芝 超音波画像化装置
WO2003057881A1 (fr) 2001-12-28 2003-07-17 Chugai Seiyaku Kabushiki Kaisha Procede de stabilisation d'une proteine
US7317091B2 (en) * 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
US8188231B2 (en) * 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
WO2003074679A2 (en) 2002-03-01 2003-09-12 Xencor Antibody optimization
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
AU2003236018A1 (en) 2002-04-09 2003-10-20 Kyowa Hakko Kirin Co., Ltd. METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcGamma RECEPTOR IIIa
CA2482881C (en) 2002-05-23 2016-11-08 Sunnybrook And Women's College Health Sciences Centre Diagnosis of hepatocellular carcinoma
TW200413406A (en) * 2002-08-26 2004-08-01 Kirin Brewery Peptides and drugs containing the same
AU2002338020A1 (en) 2002-09-04 2004-03-29 Chugai Seiyaku Kabushiki Kaisha Antibody against blood-solubilized n-terminal peptide in gpc3
WO2004023145A1 (ja) 2002-09-04 2004-03-18 Perseus Proteomics Inc. Ｇｐｃ3の検出による癌の診断方法
AU2002328429A1 (en) 2002-09-04 2004-03-29 Chugai Seiyaku Kabushiki Kaisha CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
US20090010920A1 (en) * 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US20080008710A1 (en) * 2003-09-04 2008-01-10 Hiroyuki Aburatani Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma
ITBO20040008U1 (it) 2004-02-03 2004-05-03 Tonazzi S R L Macchina per il riempimento e la chiusura di tubetti
ATE486610T1 (de) 2004-07-09 2010-11-15 Chugai Pharmaceutical Co Ltd Anti-glypican-3-antikörper
AU2005277567A1 (en) * 2004-08-16 2006-03-02 Medimmune, Llc Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity
EP1800693B1 (en) 2004-08-24 2013-07-17 Chugai Seiyaku Kabushiki Kaisha Adjuvant therapy with the use of anti-glypican 3 antibody
TWI468514B (zh) * 2004-10-26 2015-01-11 Chugai Pharmaceutical Co Ltd Sugar chain modified phosphatidylinositol glyphosyl 3 antibody
US20070087005A1 (en) 2005-10-14 2007-04-19 Lazar Gregory A Anti-glypican-3 antibody

Also Published As

Publication number Publication date
KR20070050963A (ko) 2007-05-16
KR20130103580A (ko) 2013-09-23
EP1800693A1 (en) 2007-06-27
CN102698267B (zh) 2017-07-21
JPWO2006022407A1 (ja) 2008-05-08
HK1107010A1 (en) 2008-03-28
EP1800693A4 (en) 2008-12-17
CN101014367A (zh) 2007-08-08
JP4733042B2 (ja) 2011-07-27
US7871613B2 (en) 2011-01-18
CN101014367B (zh) 2012-07-04
CN102698267A (zh) 2012-10-03
ES2422898T3 (es) 2013-09-16
TWI377951B (pl) 2012-12-01
US20070269444A1 (en) 2007-11-22
DK1800693T3 (da) 2013-10-21
KR101300546B1 (ko) 2013-09-02
PT1800693E (pt) 2013-08-23
SI1800693T1 (sl) 2013-11-29
TW200612988A (en) 2006-05-01
EP1800693B1 (en) 2013-07-17
WO2006022407A1 (ja) 2006-03-02

Similar Documents

Publication Publication Date Title
HK1107010A1 (en) Adjuvant therapy with the use of anti-glypican 3 antibody
HK1087131A1 (en) Anti-igfr1 antibody therapeutic combinations
EP1572131A4 (en) ANTIBODY THERAPY
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL183458A0 (en) Anti-il-1r1 single domain antibodies and therapeutic uses
IL178816A0 (en) The treatment of childhood asthma
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
IL179462A0 (en) Use of the receptor gpr86
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
EP1824467A4 (en) APOGOSSYPOLON AND ITS USES
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
EP1789027A4 (en) Therapeutic Use of Anti- TF Antigen Antibodies
EP1835027A4 (en) NEW ANTIGEN PEPTIDE AGAINST CANCER AND APPLICATIONS
TWI368509B (en) Antituberculous therapeutic drugs and kit containing the same
HK1079776A1 (en) The synthesis of 1,3-dihydro-2h-3-benzazepin-2-onecompounds, and the use thereof
HK1155670A1 (en) Therapeutic use of anti-cs1 antibodies
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EP1829969A4 (en) NOVEL POLYPEPTIDE AND USE THEREOF
TWI365187B (en) 7-azaindoles and the use thereof as therapeutic agents
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0401398D0 (en) New theraputic use
ZA200802541B (en) Human antibodies against IL13 and therapeutic uses
GB0515906D0 (en) Mixtures of antigen and adjuvant
ZA200705455B (en) Silicon compounds and their use
GB0423927D0 (en) The treatment of IBD